INVISIBLE DISEASE - CHANGING THE WAY WE THINK ABOUT PSORIASIS -

Silver Spike

Case Film

Presentation Image

TitleINVISIBLE DISEASE - CHANGING THE WAY WE THINK ABOUT PSORIASIS -
BrandJANSSEN PHARMACEUTICAL K.K.
Product / ServicePSORIASIS DISEASE AWARENESS
CategoryF01. Pharma: Disease Awareness & Understanding
EntrantOZMA INC Tokyo, JAPAN
Idea Creation OZMA INC Tokyo, JAPAN
Idea Creation 2 1-10, INC. Kyoto, JAPAN
Media Placement OZMA INC Tokyo, JAPAN
PR OZMA INC Tokyo, JAPAN
Production OZMA INC Tokyo, JAPAN
Production 2 TOW CO.,LTD Tokyo, JAPAN
Production 3 TAIYO KIKAKU CO., LTD. Tokyo, JAPAN
Production 4 MASSIVE MUSIC Tokyo, JAPAN
Production 5 MIGHTY MYT, INC. Tokyo, JAPAN

Credits

Name Company Position
Koshiro Nomura Ozma Inc. Executive Producer / Senior PR Director
Yui Hidaka Ozma Inc. PR Director
Maiko Banno Ozma Inc. Senior PR Director
Tomoya Shiraishi Ozma Inc. PR Planner
Kazuma Tsugawa Ozma Inc. PR Planner
Sachi Okada Ozma Inc. PR Planner
Kenji Iijima Ozma Inc. PR Planner
Ryo Arimichi Ozma Inc. PR Planner
Hirokazu Matsushige 1-10, Inc. Creative Director
Ayuko Kojima 1-10, Inc. Art Director / Designer
Yoshio Takimoto 1-10, Inc. Copy Writer / Planner
Kazumi Ueda 1-10, Inc. Experience Director
Yuka Kamakura 1-10, Inc. Planner
Riho Kawai 1-10, Inc. Illustrator
Yukiko Murai 1-10, Inc. Producer
Haruka Miyagoshi 1-10, Inc. Web Designer
Kana Fujikura 1-10, Inc. Web Designer
Takashi Kibe TOW Co.,Ltd. Producer
Yuji Kanematsu TOW Co.,Ltd. Producer
Ryo Fukushima TOW Co.,Ltd. Event Director
Yohji Nakamura TOW Co.,Ltd. Event Director
Yuriko Kunii OFFICE BEE Art Design & Art Production
Moe Ikeda Taiyokikaku.co.ltd,. Director
Yasuo Igeta Taiyokikaku.co.ltd,. Cinematographer
Shuhei Hosokawa Taiyokikaku.co.ltd,. Producer
Shuhei Ohashi Taiyokikaku.co.ltd,. Editor
Akari Tatsumi Taiyokikaku.co.ltd,. Mixer
Ayami Fujiwara Taiyokikaku.co.ltd,. Mixer assistant
Junya Terui Massive Music Music Producer
Tamon Fujimi Massive Music Music Producer
Sayaka Ryuzaki Massive Music Music Producer
Tomohiro Rikimaru mighty myT, Inc. Technical Director
Yohei Kayamoto mighty myT, Inc. Frontend Engineer
Akitoshi Kubo mighty myT, Inc. Frontend Engineer
Yuko Tsushima Ozma Inc. PR Planner

Why is this work relevant for PR?

Because the condition is vivid in physical appearance, we especially incorporated visual elements throughout the campaign to help the public visualize what it means to live with this disease. We focused to create visual features such as temporary tattoos of psoriasis plaques, an art exhibition where beautiful artworks revealed hidden physical and emotional burden, and VR to experience the struggled daily life with psoriasis. The initiative was designed to have an impact by symbolizing psoriasis in unexpected, different ways. The public was encouraged to take photos of such meaningful activities, and social media engagement was increased with photographing.

Describe any restrictions or regulations regarding Healthcare/RX/Pharma communications in your country/region including:

It is prohibited to advertise medicines for medical treatment except for medical or pharmaceutical articles in newspapers or magazines meant for medical staffs.

Describe the target audience and why your work is relevant to them.

We targeted to educate and engage with the general public, and also to empower patients. Our project increased media and public understanding of psoriasis, and created immersive experiences to help the public visualize and empathize with its devastating impact. This motivated patients to seek support and live their best life.

Background

Japan is where stigma of PSORIASIS, a skin condition that causes painful raised plaques, is one of the most critical in the world. The word for psoriasis (kansen) sounds exactly same as the word for contagious in Japanese, which has led to the common misconception that the condition is contagious. This social stigma has a devastating impact, leading patients to isolate themselves and avoid social interactions. It also limits patients’ access to optimal treatment, as many do not continue to seek support following diagnosis and first-line treatment while new and improved biological treatments are becoming available. Issues around awareness and understanding are compounded by a lack of accurate public information about psoriasis, and by low media interest. At the launch of TREMFYA® (guselkumab), a new biologic therapy, Janssen identified an opportunity to disrupt the landscape, change the way psoriasis is perceived, and demonstrate Janssen’s leadership and commitment to patients.

Describe the creative idea (20% of vote)

To remove the stigma associated with psoriasis, we wanted the general public to really understand what it means to live with this disease. Experiential activities were central to fostering deep understanding and empathy for those with psoriasis. Because the condition is vivid in physical appearance, we especially incorporated immersive visual elements throughout the campaign to ensure high engagement and to act as a powerful educational tool. Such meaningful actions included offering temporary tattoos of psoriasis plaques to media, holding an art exhibition where beautiful artworks revealed hidden physical and emotional burden, and VR to experience the struggled daily life with psoriasis. We also assigned a well-known model who revealed to be living with psoriasis as campaign Ambassador, hoping that her beautiful appearance with unknown struggles would change the way psoriasis is perceived by media and the general public.

Describe the strategy (30% of vote)

Our approach was to challenge public and patients’ bias that its problems were misleading name and the physical appearance. Although the symptom was exposed, its true cost was INVISIBLE such as social isolation and limiting treatment opportunities. Strategy built on three pillars: Educate – Engage – Empower Educate: Increase media and public understanding of psoriasis by providing comprehensive information about the condition and its burden. Engage: Create immersive experiences to help the public visualize, empathize and truly engage with the devastating impact of these diseases on people’s lives. Empower: Motivate those living with psoriasis to seek support and live their best life by providing inspiration and improving knowledge of the current treatment options available. We targeted general key media including National newspapers, General magazines and WEB. To increase social media engagement, we assigned Ambassador with strong profile with social media community and focused to create visual features to encourage photographing.

Describe the execution (20% of vote)

In October 2018, a psoriasis awareness initiative was launched via The Invisible Museum art exhibition to showcase the daily struggles of patients through beautiful artworks that reveal their hidden messages when photographed with a flash. The initiative was supported by a comprehensive media relations campaign featuring well-known Japanese model, Angelica Michibata who has a strong profile with the public and patient community, having recently revealed on social media she is living with psoriasis. Janssen also supported a range of education initiatives to improve psoriasis awareness and understanding amongst media and the general public, including a media seminar in collaboration with eight other pharmaceutical companies and a public awareness event on World Psoriasis Day. To support the initiative, a dedicated public website was launched featuring comprehensive information about psoriasis and inspirational personal stories. Meanwhile, an educational event series was held where Angelica, expert dermatologists and a leading patient organization were involved.

List the results (30% of vote) – must include at least two of the following tiers:

•USD 8.5m in earned media including >500 articles with potential reach of 2.5bn views, exceeding target by 2,500% •12m social media engagements •Psoriasis was the 4th most searched term on Google on 6 October, exceeding expectations of a 50% increase in searches •15.4% increase in awareness of psoriasis (from 24.7% to 40.1%), exceeding campaign target of 10% •12.9% increase in public understanding that psoriasis is not contagious (from 17.2% to 30.1%), more than double the 5% target •Market for biologic treatments grew by 28% •A qualitative survey showed that almost a third of patients were less concerned about their appearance following the art exhibition •Received positive feedback from a leading patient organization, which described the campaign as ‘first-of-its-kind’ and ‘critical to empowering people with psoriasis’ to seek better treatment options •The head of Japan Society of Psoriasis Research publicly recognized this campaign’s contribution to improving understanding of psoriasis

Links
Website URL